By Sruthi Shankar
(Reuters) -Britain’s top share index dipped on Thursday, weighed down by Rio Tinto and healthcare stocks, while the midcap index struggled after hitting a two-month peak earlier as prospect of higher U.S. interest rates kept investors wary.
The FTSE 100 dropped 0.1%, with Rio Tinto falling 3.8% as the miner traded without entitlement to the latest dividend payout.
Drugmaker GSK slid 2.8% after heavy selling in the previous session amid chatter over potential negative implication from U.S. lawsuits over Zantac, a drug that was withdrawn in 2019. Haleon, a consumer health company recently spun off from GSK, dropped 7.9%.
The domestically focussed FTSE 250 index also gave up earlier gains to slip 0.1%.
Global equities climbed on Wednesday after softer-than-expected U.S. inflation data reduced bets of a supersized rate hike by the Federal Reserve next month. However, policymakers were quick to say that they will continue to tighten monetary policy until price pressures are fully broken.
“Market pricing suggests that investors are more dovish than what we would expect the Fed to deliver,” said Karim Chedid, BlackRock’s head of investment strategy for its iShares unit in the EMEA region. “You could see more volatility in rate and equity markets.”
A stock market rally since June lows has helped drive the FTSE 100 and the midcap FTSE 250 near two-month highs, but many strategists doubt if the gains can sustain amid growing concerns of a recession.
Focus will now be on the preliminary reading of Britain’s GDP on Friday, expected to show a contraction during the second quarter.
Britain will only feel the full impact of higher interest rates in late 2023 and there is unlikely to be any return of quantitative easing for at least a few years, Bank of England chief economist Huw Pill said.
London-listed shares of Antofagasta slipped 1.6% after the Chilean miner reported a fall in half-year profit.
UK-listed shares of Dubai-based payments processor Network International jumped 11.5% as it announced a stock buyback programme and reported strong half-year results.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Uttaresh.V and Shailesh Kuber)
Global Banking & Finance Review
Why waste money on news and opinions when you can access them for free?
Take advantage of our newsletter subscription and stay informed on the go!
Top Stories1 day ago
Dollar climbs to near 150 vs yen after US shutdown avoided, data
Top Stories20 hours ago
Visa launches $100 million venture fund for generative AI startups
Top Stories19 hours ago
Rouble recovers slightly after slide past 100 vs dollar
Top Stories1 day ago
Hungarian and US scientists win Nobel for COVID-19 vaccine discoveries